All Research on Biotech

Insight

Case Studies
Case Studies

Alexion Pharmaceuticals, Inc.: Focus on ultra-rare diseases as a revenue and profit driver

In 2007, Alexion gained marketing approval for Soliris, which has since become the world’s single most expensive orphan drug. This case study analyzes Alexion's success with Soliris, potential challenges, and how it is combatting these going forward.

Published By MarketLine
$495
Buy
Report
Report

The Orphan Drug Market Outlook to 2017

This report provides an analysis of the orphan drug market. It comprises brands that have gained US FDA orphan drug approval, as well as Phase III pipeline candidates that have gained an orphan drug designation from the FDA.

Published By Datamonitor
$2800
Buy
Report
Report

Hemophilia Pipeline Overview – Once-a-week prophylaxis may soon become a reality

Datamonitor provides an overview of and profiles key hemophilia A and B pipeline products launching in the near future in the US and five major EU markets (France, Germany, Italy, Spain, and the UK).

Published By Datamonitor
$2800
Buy

View all Insight >>

Profiles

Company Profile
Company Profile

Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries (Teva or 'the company') is the leading generic pharmaceutical company. It is engaged in the development, production and marketing of generic, proprietary branded pharmaceuticals and active pharmaceutical ingredients. The company conducts its operations primarily in the Americas, Europe and Asia. It is headquartered in Petach Tikva, Israel, and employed 45,000 people as on December 31, 2013.

Published By MarketLine
$175
Buy
Company Profile
Company Profile

Baxter International Inc.

Baxter International (Baxter or 'the company') is engaged in the development, manufacture and marketing of products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. The company operates in North America, Europe, Asia Pacific and Latin America. It is headquartered in Deerfield, Illinois, and employed about 61,000 people as of December 31, 2013.

Published By MarketLine
$175
Buy
Company Profile
Company Profile

CSL Limited

CSL (or 'the group') is a leading global provider of biotherapies to treat and prevent serious and rare medical conditions. The group operates globally through its human health businesses that include the operations of CSL Behring, CSL Bioplasma and CSL Biotherapies. CSL is headquartered in Victoria, Australia, and employed about 12,196 people as of June 30, 2014.

Published By MarketLine
$175
Buy

View all Profiles >>

No help is available.